Collins Property Group Full Year 2025 Earnings: EPS: R1.69 (vs R4.25 in FY 2024)
Revenue: R1.26b (up 7.2% from FY 2024).
Net income: R557.2m (down 51% from FY 2024).
Profit margin: 44% (down from 97% in FY 2024).
EPS: R1.69 (down from R4.25 in FY 2024).
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Collins Property Group shares are down 12% from a week ago.
It's necessary to consider the ever-present spectre of investment risk. We've identified 5 warning signs with Collins Property Group (at least 1 which doesn't sit too well with us), and understanding these should be part of your investment process.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
High Growth Tech Stocks in Australia for June 2025
As the Australian market flirts with fresh intraday records, particularly with the ASX200 hovering around 8,650 points, investor sentiment appears cautiously optimistic despite recent volatility in the tech sector. In this environment, identifying high growth tech stocks requires a keen eye for companies that can navigate market fluctuations and capitalize on emerging opportunities, making them potential standouts amidst broader economic uncertainties. Name Revenue Growth Earnings Growth Growth Rating Gratifii 42.14% 113.99% ★★★★★★ Pro Medicus 22.19% 23.49% ★★★★★★ WiseTech Global 20.15% 25.52% ★★★★★★ Wrkr 57.01% 116.83% ★★★★★★ AVA Risk Group 29.15% 108.15% ★★★★★★ BlinkLab 65.54% 64.35% ★★★★★★ Echo IQ 61.50% 65.86% ★★★★★★ Immutep 70.42% 42.39% ★★★★★☆ Adveritas 52.34% 88.83% ★★★★★★ SiteMinder 19.81% 70.04% ★★★★★☆ Click here to see the full list of 47 stocks from our ASX High Growth Tech and AI Stocks screener. We'll examine a selection from our screener results. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Energy One Limited offers software solutions, outsourced operations, and advisory services for wholesale energy and environmental markets across Australasia and Europe, with a market cap of A$468.08 million. Operations: Energy One Limited generates revenue primarily from its energy software industry segment, amounting to A$55.81 million. The company operates within the wholesale energy, environmental, and carbon trading markets in Australasia and Europe. Energy One, recently added to the S&P/ASX All Ordinaries Index, showcases robust growth dynamics within Australia's tech sector. With a remarkable 273.3% earnings increase over the past year, significantly outpacing the software industry's average of 5.6%, Energy One demonstrates strong market performance and potential for sustained growth. This is further underscored by its forecasted annual earnings growth of 42%, which eclipses the broader Australian market's expectation of 11.6%. However, it is crucial to note significant insider selling in recent months which may warrant cautious optimism among investors. Despite this, with a solid return on equity projected at 15.5% in three years and positive free cash flow status, Energy One stands as a compelling case of a company leveraging high-quality earnings and strategic market positioning to potentially shape future industry standards. Click here to discover the nuances of Energy One with our detailed analytical health report. Review our historical performance report to gain insights into Energy One's's past performance. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Infomedia Ltd is a technology company that develops and supplies electronic parts catalogues, service quoting software, and e-commerce solutions for the automotive industry globally, with a market cap of A$471.74 million. Operations: Infomedia generates revenue primarily through its publishing segment, specifically in periodicals, amounting to A$142.41 million. The company focuses on providing digital solutions for the automotive industry worldwide. Infomedia, navigating the competitive tech landscape in Australia, has demonstrated notable financial agility with a significant 61.3% earnings growth over the past year, outperforming the software industry average of 5.6%. This growth trajectory is supported by an aggressive R&D investment strategy, crucial for maintaining its edge in innovation and service delivery in automotive software solutions. The company's revenue is also on an upward curve at 6.9% annually, surpassing the broader Australian market's growth rate of 5.6%. Despite recent executive changes that saw Joanne Hawkins resign as Company Secretary and Jon Brett step down as Chair due to health reasons, Infomedia's robust forecasted annual earnings growth of 19.9% and a promising return on equity projection of 21.7% position it well for future expansion within this dynamic sector. Navigate through the intricacies of Infomedia with our comprehensive health report here. Evaluate Infomedia's historical performance by accessing our past performance report. Simply Wall St Growth Rating: ★★★★★☆ Overview: SiteMinder Limited develops, markets, and sells online guest acquisition platforms and commerce solutions for accommodation providers globally, with a market cap of A$1.32 billion. Operations: The company's primary revenue stream comes from its software and programming segment, generating A$203.65 million. SiteMinder, a trailblazer in the Australian tech scene, is capitalizing on the global shift towards digital hospitality solutions. With an impressive 19.8% annual revenue growth and a projected earnings surge of 70% per year, the company is strategically investing in R&D to innovate further and stay ahead in the competitive market. This focus on development has led to significant advancements in their platform, enhancing user experience and efficiency for hotel operators worldwide. Despite not yet being profitable, SiteMinder's robust growth metrics and future profitability projections underscore its potential as a key player in transforming how hotels engage with technology. Dive into the specifics of SiteMinder here with our thorough health report. Understand SiteMinder's track record by examining our Past report. Click this link to deep-dive into the 47 companies within our ASX High Growth Tech and AI Stocks screener. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:EOL ASX:IFM and ASX:SDR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Bloomberg
36 minutes ago
- Bloomberg
Stock Movers: Netflix, Lockheed Martin, Vera Bradley
On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Scarlet Fu, Alix Steel, David Gura and Norah Mulinda. - Netflix (NFLX) shares soared today as investors like what CEO Greg Peters had to say at a conference in London. Speaking at the event, the streamer's leader said he was optimistic about Netflix's growth prospects despite President Donald Trump's threats to impose tariffs on the film industry. - Lockheed Martin (LMT) shares fell as much as 7% on the news that the Air Force is cutting in half its request to Congress for F-35s. A Defense Department procurement request document sent to Capitol Hill this week asked for 24 of the planes, down from 48 that was forecast last year. The proposed cut is significant because the Air Force is the largest customer for the world's biggest weapons program. The scaling back of the F-35 request may reflect one way the service is revising its funding for fiscal 2026 to comply with Defense Secretary Pete Hegseth's plan to shift projected US military spending by 8% over the next five years. - Vera Bradley (VRA) shares fell as much as 24%, a record drop, after the retailer suspends guidance and announced the departure of its CEO. The pulled guidance reflects executive and board leadership changes and 'significant uncertainty surrounding the consumer environment,' the company said.
Yahoo
2 hours ago
- Yahoo
Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions
Tandem Diabetes Care, Inc. recently announced a significant collaboration with Abbott Laboratories to integrate Abbott's upcoming dual glucose-ketone sensor with Tandem's insulin delivery systems. This and other collaborations, such as the agreement with Sequel Med Tech, align with Abbott's strategic focus on enhancing diabetes care. Abbott's shares rose 3% over the last quarter, aligning closely with broader market trends, which advanced 13% over the past year. The company's robust product approvals and partnerships, alongside positive market sentiment, likely reinforced investor confidence in Abbott's growth trajectory amid generally favorable market conditions. You should learn about the 1 possible red flag we've spotted with Abbott Laboratories. Find companies with promising cash flow potential yet trading below their fair value. The recent collaboration between Tandem Diabetes Care, Inc. and Abbott Laboratories to integrate Abbott's dual glucose-ketone sensor has the potential to enhance Abbott's market positioning in diabetes care. This partnership, along with other strategic agreements, could support revenue growth in Abbott's Diabetes Care segment, though challenges such as tariffs and VBP program impacts in China remain. Abbott's five-year total return, including share price and dividends, stands at 63.31%, showcasing strong longer-term performance, despite some earnings forecast pressure. In the past year, Abbott's shares have risen above the US Medical Equipment industry, which saw a return of 8.2%. This outperformance over a shorter time horizon indicates that investor confidence remains buoyant. However, the expectation of declining earnings over the next three years, with a 10.1% decrease per year, highlights forecast challenges. This contrasts with a forecasted revenue growth of 6.9% annually, which is slower than the broader US market growth rate of 8.6% per year. The current share price of US$133.06 reflects a modest 5.2% discount to the consensus analyst price target of US$140.41, suggesting a perception of fair valuation compared to expected earnings growth and projected revenue increases. Insights from our recent valuation report point to the potential undervaluation of Abbott Laboratories shares in the market. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:ABT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
